Why is Suven Life Scie. falling/rising?

As of 10-Jul, Suven Life Sciences Ltd is experiencing a price increase, currently at Rs 268.90, reflecting a rise of Rs 3.9 or 1.47%. The stock has shown strong performance, with a 1-week return of +8.65% and a 1-month return of +19.59%. It is trading above all key moving averages and has recently outperformed its sector by 2.04%. However, despite these positive short-term movements, the company faces significant challenges, including operating losses and a weak long-term fundamental strength, with net sales and operating profit declining sharply over the past five years. Additionally, the company has reported negative results for the last three consecutive quarters, which raises concerns about its financial health.
In the broader market context, Suven Life Sciences has significantly outperformed the benchmark Sensex, which has seen a slight decline of -0.06% over the past week. The stock's year-to-date return of +109.02% also contrasts sharply with the Sensex's +6.46%, indicating strong investor interest despite the company's underlying financial difficulties. However, the recent decrease in institutional investor participation, who have reduced their stake by -1.13%, suggests that more knowledgeable investors may be cautious about the company's future prospects, potentially impacting its stock price stability moving forward.